News
Covid-19 research at DBM
Researchers at the DBM are working to better understand the SARS-CoV-2 virus and COVID-19 disease. The research groups of Christoph Hess and Christoph Berger have received funding from the Botnar Research Centre for Child Health (BRCCH) to…
Anne-Katrin Pröbstel receives Ellermann-Award 2020 from the Swiss Neurological Society
Anne-Katrin Pröbstel, project leader in the Clinical Neuroimmunology group at the DBM and Neurology resident at the University Hospital Basel, is the recipient of the Ellermann-Prize in Neurology 2020. She is honored for her work on the…
Daniela Finke’s research group shows how microbiota-induced tissue signals regulate ILC3-mediated antigen presentation
Frank Lehman, Nicole von Burg and colleagues from Basel, Bern, and Vienna revealed biological circuits for tissue-specific regulation of ILC3-dependent T cell responses. The study, published in Nature Communications, provides important…
Assistant professorship in cellular immunotherapy for Heinz Läubli
Prof. Heinz Läubli, DBM research group leader of the Cancer Immunotherapy lab, has started his 5 year assistance professorship in cellular immunotherapy on April 1st 2020. The professorship is supported by the Foundation for Research on…